SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000903423-17-000461
Filing Date
2017-07-10
Accepted
2017-07-10 19:24:43
Documents
1
Period of Report
2017-07-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT shabetarbutusf3.html 3  
1 OWNERSHIP DOCUMENT shabetarbutusf3.xml 3 5094
  Complete submission text file 0000903423-17-000461.txt   6641
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VIKING GLOBAL INVESTORS LP 280 PARK AVENUE NEW YORK NY 10017
Business Address
Shabet Rose Sharon (Reporting) CIK: 0001711393 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34949 | Film No.: 17958843